摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5'S,6'S,8'R,9'R,10'R,11'S,12'R,14'S,17'R,20'S,26'S,27'S,30'R,31'R,32'S,33'R,35'S,38'R,41'S)-12',33'-bis[(3S)-4-hydroxy-3-methylbutyl]-5',9',11',26',30',32'-hexamethylspiro[1,3-dioxolane-2,29'-13,34-dioxa-2,23-diazaundecacyclo[22.18.0.03,22.05,20.06,17.09,16.010,14.026,41.027,38.030,37.031,35]dotetraconta-1,3(22),15,23,36-pentaene]-8'-ol | 1010688-07-9

中文名称
——
中文别名
——
英文名称
(5'S,6'S,8'R,9'R,10'R,11'S,12'R,14'S,17'R,20'S,26'S,27'S,30'R,31'R,32'S,33'R,35'S,38'R,41'S)-12',33'-bis[(3S)-4-hydroxy-3-methylbutyl]-5',9',11',26',30',32'-hexamethylspiro[1,3-dioxolane-2,29'-13,34-dioxa-2,23-diazaundecacyclo[22.18.0.03,22.05,20.06,17.09,16.010,14.026,41.027,38.030,37.031,35]dotetraconta-1,3(22),15,23,36-pentaene]-8'-ol
英文别名
——
(5'S,6'S,8'R,9'R,10'R,11'S,12'R,14'S,17'R,20'S,26'S,27'S,30'R,31'R,32'S,33'R,35'S,38'R,41'S)-12',33'-bis[(3S)-4-hydroxy-3-methylbutyl]-5',9',11',26',30',32'-hexamethylspiro[1,3-dioxolane-2,29'-13,34-dioxa-2,23-diazaundecacyclo[22.18.0.03,22.05,20.06,17.09,16.010,14.026,41.027,38.030,37.031,35]dotetraconta-1,3(22),15,23,36-pentaene]-8'-ol化学式
CAS
1010688-07-9
化学式
C56H82N2O7
mdl
——
分子量
895.276
InChiKey
WDSMONRSWOSBRS-CDBPPFPKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    8.1
  • 重原子数:
    65
  • 可旋转键数:
    8
  • 环数:
    12.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    123
  • 氢给体数:
    3
  • 氢受体数:
    9

反应信息

  • 作为产物:
    描述:
    在 catechol-borane complex 作用下, 以 四氢呋喃 为溶剂, 反应 168.0h, 以39%的产率得到(5'S,6'S,8'R,9'R,10'R,11'S,12'R,14'S,17'R,20'S,26'S,27'S,30'R,31'R,32'S,33'R,35'S,38'R,41'S)-12',33'-bis[(3S)-4-hydroxy-3-methylbutyl]-5',9',11',26',30',32'-hexamethylspiro[1,3-dioxolane-2,29'-13,34-dioxa-2,23-diazaundecacyclo[22.18.0.03,22.05,20.06,17.09,16.010,14.026,41.027,38.030,37.031,35]dotetraconta-1,3(22),15,23,36-pentaene]-8'-ol
    参考文献:
    名称:
    Chemo-, regio-, and stereoselectivity of F-ring opening reactions in the cephalostatin series
    摘要:
    In an effort to prepare unsymmetrical cephalostatin analogues with multi-functionality, we tried the route of selective opening of the spiroketal joining rings E and F. In this study, we have tested several borane complexes (like borane-9-BBN, borane-(N-tosyl)-D-valine, and borane-catechol) with some bis-steroidal pyrazine derivatives like 3, 4, and 16 aiming at opening ring-F at only one spiro-system of the dimer. Upon testing these borane reagents, satisfying results were obtained in the case of the ketomethylene 4 using the catechol-borane complex. The structures of the resulting mono-opened and also some double-opened spiro dimers have been completely confirmed. Some of the prepared compounds were tested against three cancer cell lines: HM02 (stomach cancer), HEP G2 (hepatocellular cancer), and MCF 7 (breast cancer). (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2007.09.043
点击查看最新优质反应信息

文献信息

  • Chemo-, regio-, and stereoselectivity of F-ring opening reactions in the cephalostatin series
    作者:M. Nawasreh
    DOI:10.1016/j.bmc.2007.09.043
    日期:2008.1
    In an effort to prepare unsymmetrical cephalostatin analogues with multi-functionality, we tried the route of selective opening of the spiroketal joining rings E and F. In this study, we have tested several borane complexes (like borane-9-BBN, borane-(N-tosyl)-D-valine, and borane-catechol) with some bis-steroidal pyrazine derivatives like 3, 4, and 16 aiming at opening ring-F at only one spiro-system of the dimer. Upon testing these borane reagents, satisfying results were obtained in the case of the ketomethylene 4 using the catechol-borane complex. The structures of the resulting mono-opened and also some double-opened spiro dimers have been completely confirmed. Some of the prepared compounds were tested against three cancer cell lines: HM02 (stomach cancer), HEP G2 (hepatocellular cancer), and MCF 7 (breast cancer). (c) 2007 Elsevier Ltd. All rights reserved.
查看更多